A comparison of biodistribution and biokinetics of 99mTc-an- ti-CD66-mAb BW250/183 and 99mTc-anti- CD45-mAb YTH24.5 with regard to suitability for myeloablative radioimmunotherapy - Buchmann, I; Kull, T; Glatting, G (Eur J Nucl Med Mol Imaging, 2003)